Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 5-Europe enacts new curbs as COVID surges in absence of vaccine

Tue, 27th Oct 2020 10:57

(Adds Spain, EU)

* Anti-restriction protests turn violent in Italy

* France warns of "difficult decisions" ahead

* Trump pushes vaccines, but none yet available

By Crispian Balmer

ROME, Oct 27 (Reuters) - European governments moved on
Tuesday to impose new curbs to try to rein in a fast-growing
surge of coronavirus infections and provide economic balm to
help businesses survive the pandemic.

World leaders face an increasingly difficult task holding
the disease at bay while keeping their economies afloat as they
pin their hopes on as-yet unproven vaccines.

"We are dealing with exponential growth," German Economy
Minister Peter Altmaier told a virtual German-French economic
conference in Berlin. "In Germany the number of new infections
is rising by 70-75% compared to the week before."

The United States, Russia, France, Sweden, Poland and other
countries have registered record numbers of infections in recent
days as autumn turns to winter in the Northern Hemisphere and
people socialise indoors where the risk of infection is higher.

More than 43.4 million people have been infected by the
coronavirus globally and 1,158,056? have died, according to a
Reuters tally, with the United States leading the way in the
number of infections and deaths.

Hundreds of protesters took to the streets across Italy on
Monday to vent their anger at the latest round of restrictions,
including early closing for bars and restaurants, with
demonstrations in some cities turning violent.

In the financial capital Milan, youths hurled petrol bombs
at police, who responded with volleys of tear gas. In nearby
Turin, luxury shops had their windows smashed and some were
ransacked, leading to the arrest of 10 rioters.

In France, Interior Minister Gerald Darmanin warned the
country to prepare for "difficult decisions" after some of the
strictest restrictions currently in place anywhere in Europe
have failed to halt the spread of the disease.

The Czech government will ask lawmakers to extend its
emergency powers until Dec. 3, Prime Minister Andrej Babis said
on Tuesday, as it tries to stem one of the strongest surges in
infections in Europe.

BRAIN FUNCTION AFFECTED

There have been at least 8.54 million reported infections
and 251,000 deaths caused by coronavirus in Europe so far,
according to latest Reuters data. The continent registered a
record 230,892 new cases on Monday, up from 67,739 on Oct. 1.

Authorities in Russia, which with 1.55 million infections
has the world's fourth largest COVID-19 case load, ordered
people to wear facemasks in some public places and asked
regional authorities to consider shutting bars and restaurants
overnight.

New infections in Belgium, among the hardest-hit countries
in Europe, hit a high of more than 18,000 on Oct. 20, almost a
10-fold increase from the high of a spring wave of the pandemic.

The country is expected to decide by this weekend whether a
return to a nationwide lockdown is required.

Even Germany, widely praised for its initial response to the
pandemic, signalled concern on Tuesday over rising infections,
with Altmaier saying the country was likely to reach 20,000
cases a day by the end of this week.

Spain's wine-producing region of La Rioja ordered the
closure of restaurants and bars in its two largest towns for a
month. A nationwide curfew has been in place since Sunday.

A gauge of global stock markets fell and the U.S. dollar
slipped on Tuesday as investors grappled with a surge in
coronavirus cases and uncertainty over the impending U.S.
election.

Adding to the gloomy sentiment, a new study by Imperial
College London found that antibodies against the new coronavirus
declined rapidly in the British population during summer,
suggesting protection after infection may not be long-lasting.
Recovering patients may also suffer a decline in
brain function, researchers warned.

In the United States, the number of hospitalised COVID-19
patients is at a two-month high, straining health care systems
in some states. The U.S. death toll leads the world at more than
225,300.

"Until November 4th., Fake News Media is going full on
Covid, Covid, Covid," President Donald Trump, facing a tough
re-election battle on Nov. 3, tweeted on Tuesday in an
often-repeated refrain without offering evidence. "We are
rounding the turn. 99.9%."

Trump has often promoted vaccines as the answer, but none
has yet won international approval. Russia in August became the
first country to grant regulatory approval for a vaccine after
less than two months of human testing, raising eyebrows among
sceptical scientists in the West.

A vaccine being developed by the University of Oxford and
AstraZeneca Plc produces an immune response in both old
and young adults, the company said on Monday, raising hopes of a
path out of the gloom.

But only a share of the EU population can be inoculated
before 2022, should a vaccine become available, EU officials
said in an internal meeting on Tuesday.

The warning comes in spite of the fact that the 27-nation
bloc, with a population of 450 million, has secured more than a
billion doses of potential vaccines from three drugmakers.

(Reporting by Reuters bureaux; Writing by Crispian Balmer and
Nick Macfie; Editing by Alison Williams and Jon Boyle)

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.